This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

26 Apr 2012

Amgen Acquires Turkish Pharma for $700M

Amgen will acquire a privately held Turkish pharmaceutical company for $700 million in cash.

Amgen will acquire 95.6% Mustafa Nevzat Pharmaceuticals (MN), a privately held Turkish pharmaceutical company, for $700 million in cash.


Mustafa Nevzat is a leading supplier of pharmaceuticals to hospitals and a major supplier of injectable medicines in Turkey. The company had revenues of approximately $200 million in 2011.


Robert A. Bradway, president and chief operating officer at Amgen, said,"Amgen is dedicated to making our innovative medicines available to patients in major markets around the world. Together with MN’s staff and management team, we plan to grow our business with high quality and innovative medicines in Turkey and the surrounding region.”



Related News